These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10620731)

  • 21. Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moieties.
    Renzi G; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2000 Apr; 10(7):673-6. PubMed ID: 10762051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.
    Winum JY; Casini A; Mincione F; Starnotti M; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jan; 14(1):225-9. PubMed ID: 14684332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV.
    Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Sep; 13(6):419-42. PubMed ID: 9825306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Starnotti M; Supuran CT
    Bioorg Med Chem Lett; 2003 Sep; 13(17):2867-73. PubMed ID: 14611846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes.
    Supuran CT; Scozzafava A; Ilies MA; Briganti F
    J Enzyme Inhib; 2000; 15(4):381-401. PubMed ID: 10995069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
    Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
    Scozzafava A; Briganti F; Ilies MA; Supuran CT
    J Med Chem; 2000 Jan; 43(2):292-300. PubMed ID: 10649985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic Anhydrase Inhibitors. Synthesis of Topically Effective Intraocular Pressure Lowering Agents Derived from 5-(omega-Amino- alkylcarboxamido)-1,3,4-Thia- diazole-2-Sulfonamide.
    Barboiu M; Supuran CT; Menabuoni L; Scozzafava A; Mincione F; Briganti F; Mincione G
    J Enzyme Inhib; 1999 Nov; 15(1):23-46. PubMed ID: 10938532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents.
    Bragagni M; Bozdag M; Carta F; Scozzafava A; Lanzi C; Masini E; Mura P; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(18):6223-7. PubMed ID: 26319622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with N-hydroxysulfonamides--a novel class of intraocular pressure lowering agents.
    Mincione F; Menabuoni L; Briganti F; Mincione G; Scozzafava A; Supuran CT
    J Enzyme Inhib; 1998 Jul; 13(4):267-84. PubMed ID: 9795865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach.
    Agrawal VK; Banerji M; Gupta M; Singh J; Khadikar PV; Supuran CT
    Eur J Med Chem; 2005 Oct; 40(10):1002-12. PubMed ID: 15961191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF; Maren TH
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thieno[2,3-b]furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD; Halczenko W; Prugh JD; Smith RL; Sugrue MF; Mallorga P; Michelson SR; Randall WC; Schwam H; Sondey JM
    J Med Chem; 1992 Aug; 35(16):3027-33. PubMed ID: 1501230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topically active ocular carbonic anhydrase inhibitors: novel biscarbonylamidothiadiazole sulfonamides as ocular hypotensive agents.
    Pierce WM; Sharir M; Waite KJ; Chen D; Kaysinger KK
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):360-5. PubMed ID: 8516347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups.
    Bozdag M; Ferraroni M; Carta F; Vullo D; Lucarini L; Orlandini E; Rossello A; Nuti E; Scozzafava A; Masini E; Supuran CT
    J Med Chem; 2014 Nov; 57(21):9152-67. PubMed ID: 25310626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents.
    Lo YS; Nolan JC; Maren TH; Welstead WJ; Gripshover DF; Shamblee DA
    J Med Chem; 1992 Dec; 35(26):4790-4. PubMed ID: 1479580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.